Pentoxifylline and Its Effects on Pleural Fibrosis
Author Information
Author(s): P. Entzian, M. Schlaak, U. Seitzer, Y. Acil, M. Ernst, P. Zabel
Primary Institution: Forschungszentrum Borstel, Germany
Hypothesis
Can pentoxifylline inhibit the fibrogenic activity of pleural effusions and transforming growth factor-b?
Conclusion
Pentoxifylline may offer a new approach in the therapy of pleural and pulmonary fibrosis by inhibiting fibroblast proliferation and collagen synthesis.
Supporting Evidence
- TGF-b levels in pleural effusions correlated with the extent of pleural thickenings.
- Pentoxifylline inhibited fibroblast proliferation stimulated by TGF-b and TNFa.
- Pentoxifylline reduced collagen synthesis in fibroblasts stimulated by pleural effusions.
Takeaway
This study found that a drug called pentoxifylline can help stop the growth of certain cells that make scars in the lungs.
Methodology
The study analyzed pleural effusions from patients and tested the effects of pentoxifylline on fibroblast cultures in vitro.
Limitations
The study was limited to non-carcinomatous pleurisy and may not apply to other conditions.
Participant Demographics
49 patients with non-carcinomatous pleurisy, including various causes such as heart failure and tuberculosis.
Statistical Information
P-Value
p<0.005
Statistical Significance
p<0.05
Want to read the original?
Access the complete publication on the publisher's website